Product Name: Decernotinib
Chemical Name: (R)-2-((2-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl)amino)-2-methyl-N-(2,2,2-trifluoroethyl)butanamide
SMILES Code: CC[C@](NC1=NC(C2=CNC3=NC=CC=C32)=NC=C1)(C)C(NCC(F)(F)F)=O
CAS NO: 125494-59-9 Product: 4-Aminopyridine
Synonym: VX509; VX-509; VX 509; VRT831509; VRT-831509; VRT 831509; Adelatinib
Chemical Formula: C18H19F3N6O
Appearance: Solid powderWeb Site click
Purity: 98% (this data is for the first batch)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 8211; 4 C for short term (days to weeks) or -20 C for long term (months to years).ERK inhibitors
Solubility: Soluble in DMSO, not in water
Background Description: Decernotinib (VX-509) is an oral, selective Janus kinase 3 (JAK3) inhibitor being developed by Vertex. It may represent a new approach to treating an underlying disease mechanism that triggers inflammation in a number of debilitating diseases, including RPubMed ID:http://professional.diabetes.org/News_Display.aspx?CID=82333&TYP=9
